SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-036968
Filing Date
2014-05-09
Accepted
2014-05-09 14:11:57
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-8929_110q.htm 10-Q 909260
2 EX-31.1 a14-8929_1ex31d1.htm EX-31.1 12027
3 EX-31.2 a14-8929_1ex31d2.htm EX-31.2 12008
4 EX-32.1 a14-8929_1ex32d1.htm EX-32.1 7239
5 EX-32.2 a14-8929_1ex32d2.htm EX-32.2 7125
  Complete submission text file 0001104659-14-036968.txt   10129434

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abbv-20140331.xml EX-101.INS 1271618
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20140331.xsd EX-101.SCH 93878
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20140331_cal.xml EX-101.CAL 73712
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20140331_def.xml EX-101.DEF 603145
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT abbv-20140331_lab.xml EX-101.LAB 1938191
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20140331_pre.xml EX-101.PRE 884598
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35565 | Film No.: 14828344
SIC: 2834 Pharmaceutical Preparations